DV
Dividend Vision

ATRC — AtriCure, Inc.

AtriCure, Inc. (ATRC)

Total return is 214.6% over the past 21 years, 614.3 points behind SPY at 828.9%. Its deepest 1-year drawdown was 39.0%.

This is a single-stock equity holding in AtriCure, Inc., a medical device company, rather than a diversified ETF. The holding generates no dividend distributions and therefore carries no yield profile or regular income component. This security appeals primarily to growth-oriented investors seeking exposure to the company's business performance rather than income-focused investors.

ATRC key facts

Asset type
Stock
Asset class
Equity
Inception date
08/05/2005
Distribution frequency
None
Last close
$44.30
Market cap
$2,253,376,768
Average volume
340900.0
Beta
1.229
Payout ratio
0.0
P/E ratio
210.9524
Forward P/E
232.5581
EPS
$0.21